BSEM BioStem Technologies, Inc. - Common Stock
NASDAQ · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 12, 2026
$2.73
· of 52w range
· above low
· to high
$2.2552w low
$5.4452w high
Market Cap (MRQ)
$49M
your badges
52W Range
$2–$5
Analyst Rating
BUY
Price Target
$7
P/E
·
ROE
·
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
BSEM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$2.73
Market Cap (MRQ)
$49M
Debt/Equity (MRQ)
0.0
52W Range
$2–$5
BSEM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | BSEM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | 1.8 | · | · | · | |
| Price / Tangible Book (MRQ) | 7.8 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | BSEM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.0 | · | · | · | |
| Current Ratio (MRQ) | 1.0 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-85.6%
Next Report
Nov 11, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 12, 2026 | $-0.52 | $-0.51 | -2.0% |
| March 31, 2026 | $-0.52 | $-0.29 | -82.1% | |
| Sept. 30, 2025 | $0.03 | $0.00 | — | |
| June 30, 2025 | $-0.03 | $0.33 | -109.2% | |
| March 31, 2025 | $-0.01 | $0.02 | -149.0% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
No annual filings for BSEM
We don't have SEC filings for this ticker yet.
Income Statement
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Revenue | $8M | $11M | |
| Cost of Revenue | $3M | $685.2K | |
| Gross Profit | $5M | $10M | |
| R&D Expense | $733.6K | $2M | |
| SG&A Expense | $6M | $7M | |
| Operating Expenses | $13M | $10M | |
| Operating Income | $-8M | $112.8K | |
| Other Non-op | $-594.0K | $409 | |
| Pretax Income | $-9M | $178.0K | |
| Income Tax | $0 | $167.3K | |
| Net Income | $-9M | $10.6K | |
| EPS (Basic) | $-0.52 | $0.00 | |
| EPS (Diluted) | $-0.52 | $0.00 | |
| Shares (Basic) | 17,327,652 | 16,708,776 | |
| Shares (Diluted) | 17,327,652 | 23,419,726 | |
| EBITDA | $-8M | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Cash & Equivalents | $7M | · | |
| Receivables | $7M | · | |
| Inventory | $5M | · | |
| Prepaid Expense | $2M | · | |
| Current Assets | $21M | · | |
| PP&E (Net) | $4M | · | |
| PP&E (Gross) | $6M | · | |
| Accum. Depreciation | $1M | · | |
| Goodwill | $2M | · | |
| Intangibles | $21M | · | |
| Total Assets | $49M | · | |
| Accounts Payable | $9M | · | |
| Short-term Debt | $1M | · | |
| Current Liabilities | $21M | · | |
| Capital Leases | $1.4K | · | |
| Total Liabilities | $21M | · | |
| Long-term Debt | $0 | · | |
| Total Debt | $1M | · | |
| Common Stock | $17.8K | · | |
| Paid-in Capital | $67M | · | |
| Retained Earnings | $-39M | · | |
| Treasury Stock | $43.3K | · | |
| Stockholders' Equity | $28M | · | |
| Liabilities + Equity | $49M | · | |
| Shares Outstanding | 17,839,467 | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| D&A | $689.3K | $60.7K | |
| Amort. of Intangibles | $653.3K | $30.9K |
Profitability
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Gross Margin | 61.3% | · | |
| Operating Margin | -106.3% | · | |
| Net Margin | -113.6% | · | |
| Pretax Margin | -113.6% | · | |
| EBITDA Margin | -106.3% | · | |
| ROA | -36.8% | · | |
| ROE | -65.0% | · | |
| ROIC | -29.4% | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Current Ratio | 1.0 | · | |
| Quick Ratio | 0.6 | · | |
| Debt / Equity | 0.0 | · |
Efficiency
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Asset Turnover | 0.3 | · | |
| Inventory Turnover | 1.3 | · | |
| Receivables Turnover | 2.4 | · |
Per Share
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Book Value / Share | $1.55 | · | |
| Revenue / Share | $0.46 | · | |
| Cash / Share | $0.39 | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
No data for this statement
Not enough fundamentals data to build this statement yet.
No data for this statement
Not enough fundamentals data to build this statement yet.
No data for this statement
Not enough fundamentals data to build this statement yet.
Company insiders 10 insiders · 5 officers · 7 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jason Matuszewski | Chief Executive Officer | Sept. 17, 2026 M | 1,303,552 | 0 | 0 | $0 |
| Brandon Poe | Chief Financial Officer | Sept. 15, 2026 M | 58,062 | 0 | 0 | $0 |
| Vurst Andrew Smith-Van | Chief Operating Officer | Sept. 17, 2026 M | 1,539,809 | 0 | 0 | $0 |
| Michael A Fortunato | Chief Accounting Officer | Sept. 15, 2026 M | 68,664 | 0 | 0 | $0 |
| Barry Hassett | Chief Commercial Officer | Sept. 9, 2026 M | 5,003 | 0 | 0 | $0 |
| Kenneth Howard Warrington JR | Director | Sept. 15, 2026 M | 33,928 | 0 | 0 | $0 |
| Jodi Ungrodt | Director | Aug. 27, 2026 M | 11,295 | 0 | 0 | $0 |
| Steven D Sonenreich | Director | Aug. 27, 2026 M | 7,671 | 0 | 0 | $0 |
| Hannaway Rayna Lesser | Director | Aug. 27, 2026 M | 7,671 | 0 | 0 | $0 |
| Mark A Glickman | Director | Aug. 27, 2026 M | 7,671 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
BSEM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
Median target
$7.00
+156.4%
2 28.6%
Strong Buy
4 57.1%
Buy
1 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
1 analysts · 2026-09-29Mean target $7.00 +156.4%
Low$7.00
Mean$7.00
High$7.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| BSEM | · | · | · | · | · | · |
| ELOX | · | · | · | · | 30.1% | · |
| HYPD | $31M | -0.4 | 1318.8% | -5570.6% | -115.6% | 62.7% |
| TLPH | $56M | · | · | -51035.7% | -120.8% | · |
| SCYX | $28M | -3.7 | 450.0% | -41.8% | -18.4% | · |
| IMA | · | -0.7 | -77.1% | -5668.6% | 192.1% | · |
| FLNA | · | · | · | · | -112.1% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 12, 2026